GEMTUZUMAB OZOGAMICIN FOR RELAPSED OR PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA IN CHILDREN - EXPERIENCE OF THE POLISH PEDIATRIC LEUKEMIA AND LYMPHOMA STUDY GROUP (PPLLSG)

被引：0
|
作者：
Pawinska-Wasikowska, Katarzyna [1 ]
Bukowska-Strakova, Karolina [2 ]
Czogala, Malgorzata [1 ]
Wachowiak, Jacek [3 ]
Chaber, Radoslaw [4 ]
Szczepanski, Tomasz [5 ]
机构：
[1] Jagiellonian Univ Med Coll, Inst Pediat, Dept Pediat Oncol & Hematol, Krakow, Poland
[2] Jagiellonian Univ Med Coll, Inst Pediat, Dept Clin Immunol, Krakow, Poland
[3] Poznan Univ Med Sci, Dept Pediat Oncol Hematol & Transplantol, Poznan, Poland
[4] Univ Rzeszow, Inst Med Sci, Dept Pediat, Med Coll, Rzeszow, Poland
[5] Med Univ Silesia SUM, Dept Pediat Hematol & Oncol, Zabrze, Poland
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP269
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Gemtuzumab ozogamicin in acute myeloid leukemia
    C D Godwin
    R P Gale
    R B Walter
    Leukemia, 2017, 31 : 1855 - 1868
  • [22] Standard Administration and Fractionated Administration of Gemtuzumab Ozogamicin for Patients with Relapsed and Refractory Acute Myeloid Leukemia
    Yahagi, Yuichi
    Usui, Noriko
    Yamaguchi, Yuko
    Dobashi, Nobuaki
    Yano, Shingo
    Takei, Yutaka
    Sugiyama, Katsuki
    Takahara, Shinobu
    Ogasawara, Yoji
    Saito, Takeshi
    Kasama, Kinuyo
    Yokoyama, Hiroki
    Kamiyama, Yutaro
    Katsube, Atsushi
    Aiba, Keisuke
    BLOOD, 2012, 120 (21)
  • [23] Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia
    Chowdhury, Saeeda
    Seropian, Stuart
    Marks, Peter W.
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (09) : 599 - 600
  • [24] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience
    Naoko Hosono
    Miyuki Ookura
    Hiroaki Araie
    Mihoko Morita
    Kazuhiro Itoh
    Yasufumi Matsuda
    Takahiro Yamauchi
    International Journal of Hematology, 2021, 113 : 362 - 369
  • [25] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience
    Hosono, Naoko
    Ookura, Miyuki
    Araie, Hiroaki
    Morita, Mihoko
    Itoh, Kazuhiro
    Matsuda, Yasufumi
    Yamauchi, Takahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 362 - 369
  • [26] The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemia
    Hien K. Duong
    Matt Kalaycio
    Current Hematologic Malignancy Reports, 2009, 4 (2) : 55 - 56
  • [27] Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia
    Abedin, Sameem M.
    Badar, Talha
    Gauger, Katelyn
    Michaelis, Laura C.
    Runaas, Lyndsey
    Carlson, Karen-Sue
    Murthy, G. S. Guru
    Atallah, Ehab
    LEUKEMIA RESEARCH, 2022, 123
  • [28] Use of Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
    Walter, Roland B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S95 - S96
  • [29] TREATMENT RESULTS OF CHILDREN AND ADOLESCENTS WITH HODGKIN LYMPHOMA: REPORT OF POLISH PEDIATRIC LEUKEMIA LYMPHOMA STUDY GROUP (PPLLSG)
    Balwierz, W.
    Klekawka, T.
    Moryl-Bujakowska, A.
    Matysiak, M.
    Sopylo, B.
    Chybicka, A.
    Chaber, R.
    Szczepanski, T.
    Janik-Moszant, A.
    Wachowiak, J.
    Kaczmarek-Kanold, M.
    Kowalczyk, J. R.
    Mitura-Lesiuk, M.
    Balcerska, A.
    Stachowicz-Stencel, T.
    Wysocki, M.
    Koltan, A.
    Krawczuk-Rybak, M.
    Muszynska-Roslan, K.
    Mlynarski, W.
    Stolarska, M.
    Sobol, G.
    Mizia-Malarz, A.
    Wieczorek, M.
    Pietka, T.
    Karolczyk, G.
    Urbanek-Dadela, A.
    Urasinski, T.
    Kamienska, E.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (05) : 883 - 883
  • [30] Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
    Giles, F
    Estey, E
    O'Brien, S
    CANCER, 2003, 98 (10) : 2095 - 2104
12345